The organogallium azides (N 3 ) 2 - a (R) a Ga[(CH 2 ) 3 NMe 2 ] 1 - a ( 1a-c: R = CH 3, t Bu; a = 0, 1), (Et)(N 3 ) 2 Ga ( 2a ), and (Et)(N 3 ) 2 Ga·L ( 2b − d: L = thf, H 2 N t Bu, py, NC 7 H 13 ) are quantitatively synthesized by salt metathesis from the chloro species (Cl) 2 - a (R) a Ga[(CH 2 ) 3 NMe 2 ] 1 - a ( a = 0, 1) or EtGaCl 2 and sodium azide. The preferential ammonolysis of Ga−N 3 bonds for [Et 2 Ga(N 3 )] 3 ( 4 ) and 1 and 2 is demonstrated; e.g. the dimer Et 2 Ga(μ-NH 2 )(μ-N 3 )GaEt 2 ( 3 ) was obtained. The characterization of these compounds by means of elemental analysis, 1 H-, 13 C-, 14 N-, and 15 N-NMR, MS, and infrared ν(N 3 ) data is reported. The dynamics of the intramolecular Ga−N donor−acceptor bonded heterocycle and the azide group is discussed on the basis of variable-temperature NMR data. The barrier of activation of the bimolecular azide exchange process for (N 3 ) 2 Ga[(CH 2 ) 3 NMe 2 ] ( 1c ) amounts about 50 kJ·mol - 1 . The role of ammonia as reactive carrier gas for low-pressure metal organic chemical vapor deposition (MOCVD) of GaN with 1c as precursor is discussed.
No takes yet. Share an insight, caveat, or question.
Miehr et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: